Get the Daily Brief
Latest Biotech News
Exact Sciences Debuts Liquid Biopsy Cancerguard for Early Cancer Detection
Exact Sciences launched Cancerguard, a multi-cancer early detection (MCED) blood test designed to identify more than 50 types of cancer by detecting tumor-associated alterations in circulating DNA...
Remynd and Avidity Report Positive Clinical Data in Neurodegenerative and Neuromuscular Diseases
Remynd NV announced positive Phase IIa results for REM-127, targeting calcium homeostasis restoration in Alzheimer's disease, demonstrating reduced pathological tau, increased dopamine, and...
Partnership Integrates Ultima Genomics Sequencing with Sapio Sciences AI Lab Informatics
Ultima Genomics and Sapio Sciences formed a strategic collaboration to combine Ultima's high-throughput, cost-effective sequencing platform with Sapio's AI-powered laboratory informatics...
FDA's Uintended Data Presentation on COVID Vaccine-Linked Child Deaths Sparks Controversy
FDA officials plan to present data suggesting a link between COVID-19 vaccines and 25 reported child deaths during an upcoming vaccine advisory committee meeting, citing analysis of VAERS, a...
Long-Read Soil Metagenomics Discovers Hundreds of New Bacteria and Potential Antibiotics
Researchers employed terabase-scale long-read sequencing technology to assemble complete genomes from complex soil microbiomes, uncovering hundreds of previously unknown bacterial species. This...
Industry Giant Pharma Companies Reconsider UK Investments amid Policy Concerns
AstraZeneca announced the suspension of a $271 million expansion at its Cambridge research site, joining Merck and Lilly in delaying or halting investments in the U.K. pharmaceutical sector. These...
Multi-Target AI and Machine Learning Innovations Affect Biotech and Drug Development
Bioptimus formed a scientific advisory board comprising leading experts from top institutions to guide AI-powered foundational biology models. Additionally, developments in AI-driven diagnostics...
Emergence of Next-Generation Sequencing Technologies Enhances Throughput and Data Quality
MGI announced the T7+ high-throughput sequencer featuring multiple technological innovations such as ultra-dense DNA nanoball arrays, high-speed sample preparation, and advanced imaging, boosting...
FDA Leadership Changes and Regulatory Developments in Biotech Sector
Vinay Prasad regained additional FDA titles as Chief Medical and Scientific Officer shortly after his return as director of the Center for Biologics Evaluation and Research. The FDA's top drug...
Breakthroughs in Cancer and Immune Research Illuminate Tumor Dynamics and Therapy Resistance
New research reveals critical roles for immune checkpoint molecules like Galectin-9 expressed on leukemia stem cells as prognostic markers and therapeutic targets in acute lymphoblastic leukemia....
New Soil Metagenomic Techniques Uncover Novel Antibiotics
Researchers at Rockefeller University have developed a groundbreaking long-read sequencing technique that bypasses traditional culturing methods to explore the vast diversity of soil microbiomes....
Positive Phase II Alzheimer’s Data from Remynd NV’s Neuronal Calcium Modulator
Remynd NV reported encouraging Phase IIa clinical trial results for its novel Alzheimer's drug candidate REM-127. The orally administered small molecule restores calcium homeostasis in neurons,...
Capsida Biotherapeutics Pauses Gene Therapy Trial After First Patient Death
Capsida Biotherapeutics has suspended its phase I/II Synrgy trial testing CAP-002, a gene therapy for pediatric STXBP1 encephalopathy, following the death of the first enrolled patient. The trial...
Biopharma Capital Markets: LB Pharma IPO and Avidity Biosciences Raise Provide Momentum
LB Pharmaceuticals completed a successful NASDAQ IPO, raising $285 million to fund clinical trials for its schizophrenia and bipolar depression drug LB-102. Investor enthusiasm prompted an upsized...
Sapio Sciences and Ultima Genomics Forge Multi-Omics Technology Partnership
Sapio Sciences and Ultima Genomics announced a strategic partnership to integrate Sapio's AI-driven laboratory informatics platform with Ultima's high-throughput, low-cost sequencing technology....
FDA and Biopharma Leadership Changes Shake Industry Landscape
Vinay Prasad reclaimed chief medical and scientific officer roles at the FDA’s Center for Biologics Evaluation and Research following his recent return. Eli Lilly appointed a former FDA cell and...
Biosimilars Face Adoption Hurdles Despite Cost Savings in U.S. Market
A detailed July 2025 report highlights that FDA-approved biosimilars have generated $56.2 billion in savings since 2015 but face uneven market adoption across therapeutic areas. Despite potential...
Merck and AstraZeneca Curtail UK R&D Investments Amid Policy Uncertainty
Merck's decision to exit its London R&D hub intensifies concerns about the UK's life sciences policies, underscoring challenges the sector faces amid a competitive global landscape. AstraZeneca...
AI Advances in Peptide Therapeutics Transform Drug Discovery
AI-driven peptide design is revolutionizing the development of novel therapeutics. Professor Peter ‘t Hart and his team at the University of Münster leverage generative AI and wet-lab screening to...
Exact Sciences Launches Multi-Cancer Early Detection Liquid Biopsy Test
Exact Sciences introduced Cancerguard, a liquid biopsy test capable of detecting over 50 cancer types and subtypes through circulating tumor DNA and protein alterations. Launched at an...